How does the TRS 2°P score relate to real-world patients?

Marc P. Bonaca, Gaetano M. De Ferrari, Dan Atar, Lori D. Bash, Dominik Lautsch, Erin A. Bohula, Martin Horack, Philippe Brudi, Jean Ferrieres, Anselm K. Gitt

Research output: Contribution to journalReview article

Original languageEnglish
Pages (from-to)72-74
Number of pages3
JournalEuropean Heart Journal - Cardiovascular Pharmacotherapy
Volume4
Issue number2
DOIs
Publication statusPublished - Apr 1 2018

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Bonaca, M. P., De Ferrari, G. M., Atar, D., Bash, L. D., Lautsch, D., Bohula, E. A., Horack, M., Brudi, P., Ferrieres, J., & Gitt, A. K. (2018). How does the TRS 2°P score relate to real-world patients? European Heart Journal - Cardiovascular Pharmacotherapy, 4(2), 72-74. https://doi.org/10.1093/ehjcvp/pvy004